Фолієва кислота: бібліографія (алфавітний список англомовної літератури)

American Academy of Pediatrics, Committee on Genetics. Folic acid prevention of neural tube defects. Pediatrics 1999;104:325-327.
Agamanolis DP, Chester EM, Victor M, Kark JA, Hines, JD, Harris, JW. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology 1976;26:905-914.
Bentley JR, Ferrini RL and Hill LL. American college of preventative medicine public policy statement: Folic acid fortification of grain products in the U. S. to prevent neural tube defects. Amer J Prev Med 1999; 16 (3):2б4-267.
Beresford SAA. How do we get enough folic acid to prevent some neural tube defects? Am J Public Health 1994;84:348-50.
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong L-Y C, Gindler J, Hong S-X, and Correa A for the China-U.S. Collaborative Project for Neural Tube Defect Prevention. Prevention of neural tube defects with folic acid in China. N Engl J Med 1999;341:1485-90.
Blount ВС, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Nati Acad Sci USA; Apr 97;Vol 94:3290-95.
Botto LD, Moore CA, Khoury MJ, and Erickson JD. Neural-tube defects. N Engl J Med 1999;341:1509-1519.
Bostom AG, Rosenberg Ш, Silbershatz H, Jacques PF, Selhub J, D’Agostino RB et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann Intern Med. 1999;131:352-355.
Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D’Agostino RB, Wolf PA; et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999; 159:1077-80.
Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
Brent RL, Oakley GP, Mattison DR. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly. Pediatrics. 2000; 106:825-827.
Brouwer DAJ, Welten HTME, Reijngoud D-J, van Doormaal and Muskiet FAJ. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine. Clin Chem 1998;44:1545-1550.
Brown JE, Jacobs DR, Hartman TJ, Barosso GM, Stang JS, Gross MD, Zeuske MA. Predictors of red cell folate level in women attempting pregnancy. JAMA 1997:277:548-52.
Campbell MK, Demark-Wahnefried W, Symons M, Kalsbeek WD, Dodds J, Cowan A et al. Fruit and vegetable consumption and prevention of cancer: The Black Churches United for Better Health Project. Am J Public Health. 1999;89:1390-1396.
Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects — 1983-1991. MMWR 1991;40:513-6.
Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992;41:1-7. (No. RR-14.)
Center for Disease Control and Prevention. Folate status in women of childbearing age – United States, 1999. MMWR 2000;49:962-965.
Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-35.
Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects; implications for prevention. JAMA 1995;274:1698-1702.
Delpre G, Stark P, Niv Y. Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation. Lancet. 1999;354:740-741.
Department of Health. Report of the Committee on Medical Aspects of Food and Nutrition Policy. Report on Health and Social Subjects. 50. Folic acid and the prevention of disease. London, Stationery Office, 2000.
Dickinson CJ. Does folic acid harm people with vitamin B-12 deficiency? Q J Med 1995;88:357-64.
Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FEW, and Willett WC. Multivitamin use, folate, and colon cancer in women in the nurses’ health study. Ann Intern Med. 1998;129:517-524.
Graham I. Homocysteine in health and disease. Ann Intern Med. 1999;131:387-388.
Graham IМ, Daly LE, Refsum HM, Robinson K, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997:277;1775-81.
Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ. Results of an international round robin for serum and whole-blood folate. Clin Chem. 1996;42:1689-1694.
Hathcock JN, Troendle GJ. Oral cobalamin for treatment of pernicious anemia? J Am Med Assoc 1991; 265:96-97.
Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr 1997;65:572-3.
Institute of Medicine. (1998). Dietary Reference Intake: Folate, other В vitamins and choline. Washington DC:National Academy Press.
Itikala PR, Ruuska SE, Oakley, GP, JR, Kloeblen-Tarver A, Klein L. Preconception intake of folic acid among low-income women. JAMA. 2000;283:3074.
Jacob RA, Wu MM, Henning SM, Swendseid ME. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J Nutr 1994; 124:1072-80.
Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
Johnston RB, Jr. Folic acid: New Dimensions of an Old Friendship. Advances in Pediatrics 1997;44:231-261.
Kang S-S, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987;36:458-62.
Kang S-S, Wong PWK, Bock H-GO, Horwitz A, Grix A. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 1991;48:546-51.
Kark, JD, Selhub J, Adier B, Gofin J, Abramson JH, Friedman G, Rosenberg IH. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med. 1999;131:321-330.
Kittner SJ, Giles WH, Macko RF, Hebel JR, Wozniak MA, Wityk RJ et al. Homocyst(e)ine and risk of cerebral infarction in a biracial population. The Stroke Prevention in Young Women Study. Stroke. 1999;30:1554-1560.
Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet. 1999;354: 915-916.
Lewis CA, Pancharuniti N, Sauberlich HE. Plasma folate adequacy as determined by homocysteine level. Ann NY Acad Sci, 1992; 669:360-62.
Lewis CJ, Crane NT, Wilson BD, Yetley EA. Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Amer J Clin Nutr 1999;70:198-207.
Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Alien RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Research 57, March 15, 1997:1098-1102.
Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Hoizgang CR, Anderson PH, Seltzer D, Upson B, Lin QR. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arteriosclerosis, Thrombosis, and Vascular Biology, Vol 17, No. 6, June 1997, pp. 1157-62.
Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson BM. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 1998 Apr 9;338:1009-15.
Mark SD, Wang W, Fraumeni Jr JF, Li J-Y, Taylor PR, Wang G-Q, Guo W, Dawsey SM, Li B, and Blot WJ. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: The Linxian Nutrition Intervention Trial. Am J Epidemiol 1996;143:658-64.
Mason JB, Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology, November 1996:1727-36,1743-44.
McDonnell R, Johnson Z, Doyle A, Sayers G. Determinants of folic acid knowledge and use among antenatal women. J Publ Hith Med. 1999; 21:145-149.
MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-37.
Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad, M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. New Engl J of Med, Vol 337, No. 4, July 24, 2997, pp. 230-36.
Nygard O, Vollset SE, Refsum H, Brattstrom L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999;246:425-454. (Excellent bibliography)
Oakley GP. Folic acid-preventable spina bifida and anencephaly (Editorial). JAMA 1993:269;1292-3.
Oakley GP. Urgent need to increase folic acid consumption (Editorial). JAMA 1995:274; 1717-18.
Oakley GP, Adams MJ, Dickinson CM. More folic acid for everyone, now. J Nutr 1996:126;751S-755S.
Oakley GP. Taking a folic acid supplement probably would reduce cardiovascular disease rates in the United States. J Coronary Art Dis Index & Review; 1996:Vol II, No. 3:3, 10-12.
Oakley GP. Let’s increase folic acid fortification and include vitamin B-12. Am J of Clin Nutr 1997;65:1889-90.
Oakley, GP. Eat right and take a multivitamin. N Engl J Med 1998;338:1060-1061.
Oakley, GP. Prevention of neural-tube defects. N Engl J Med 1999:341:1546. (Letter)
Oakley, Jr GP. Falling short in preventing folic acid-preventable birth defects. In Press: 2000 Yearbook of Neonatal and Perinatal Medicine.
O’Keefe CA, Bailey LB, Thomas EA, et al. Controlled dietary folate affects folate status in nonpregnant women. J Nutr 1995; 125:2717-25.
Raats M, Thorpe L, Hurren C, and Elliott K. Changing Preconceptions. The HEA Folic Acid Campaign, 1995-1998. (Vol 2). London, Health Education Authority, 1998.
Riddell JH, Chisholm A, Williams S, Mann JI. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr 2000;71:1448-54.
Rimm ЕВ, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens С and Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-364.
Rodrigues LC, Smith PG. Use of case-control approach in vaccine evaluation: efficacy and adverse effects. Epidemiolo Rev 1999;21:56-72.
Robinson К, Мауег Е, Jacobsen DW. Homocysteine and coronary artery disease. Cleveland Clinic J of Med 1994,61:438-50.
Rossi E, Beilby JP, McQuillan BD, and Hung J. Biological variability and reference intervals for total plasma homocysteine. Ann Clin Biochem 1999;36:56-61.
Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
Selhub J, Jacques PF, Bostom AG, D’Agnostino RB, Wilson PWF, Belanger AJ, O’Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl J Med 1995;332:286-91.
Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW et al. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999;331-339.
Smithells RW, Nevin NC Seller MJ et al. Further experience of vitamin supplementation for the prevention of neural tube defect recurrences. Lancet 1983; 1:1027-31. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? (Editorial) New Engl J Med 1995;332:328-9.
Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake. (Editorial) JAMA 1993;270:2726-7.
Stevenson RE, Alien WP, Pai GS, Best R, Seaver LH, Dean J, Thompson S. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics. 2000;106:677-683.
Tucker KL, Mahnken B, Wilson PWF, Jacques P, Selhub J. Folic acid fortification of the food supply. JAMA 1996;276:1879-85.
US Department of Health and Human Services. Food and Drug Administration. Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-807.
Ubbink JB, Vermaak WJH, Van Der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. Hum and Clin Nutr 1994;1927-33.
Ubbink JB, Vermaak WJH, Van Der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
Ulrick CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford BAA, Yasui Y and Potter JD. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomark Prev. 1999;8:659-668.
Ward M, McNulty H, McPartlin J, Strain JJ, Weir DB, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM 1997;90:519-514.
Wald NJ, Bower C. Folic acid and the prevention of neural tube defects. BMJ 1995;310:1019-20.
Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA et al. A prospective study of folate intake and the risk of breast cancer. JAMA. 1999;281:1632-163.

Фолієва кислота: бібліографія (алфавітний список англомовної літератури)

500